GlassScriptPhysician profile
Sara A Peter
NPI 1720759483
$1,855.66
in general payments reported to CMS, 2019-2025
18 companies · $810 in 2025
The $810 reported for 2025 was more than what 90% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
See the full distribution for Critical Care Medicine (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $181 · 2023: $236 · 2024: $629 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $470.52 | 2024-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $256.45 | 2024-2025 | Lokelma, Andexxa |
| Lexicon Pharmaceuticals, INC. | $205.85 | 2024 | Inpefa |
| Edwards Lifesciences Corporation | $180.95 | 2022 | |
| Merck Sharp & Dohme LLC | $156.41 | 2023-2025 | Verquvo |
| Abiomed | $129.71 | 2023 | Impella |
| Novo Nordisk INC | $106.37 | 2024-2025 | |
| Pfizer INC. | $61.78 | 2024 | |
| Scpharmaceuticals INC. | $45.11 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $34.56 | 2023 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.56 | 2025 | Lifevest |
| Amgen INC. | $33.55 | 2024-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $28.37 | 2023 | Optimizer |
| Cardiva Medical, INC. | $26.94 | 2024 | Optowire |
| Inspiremd LTD | $23.25 | 2025 | Cguard Prime Carotid Stent System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $21.94 | 2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $21.07 | 2024 | Arcalyst |
| Cvrx, INC. | $19.27 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Peter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.